DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more



Ferrous Sulfate Versus Iron Amino Acid Chelate

Information source: CES University
ClinicalTrials.gov processed this data on August 23, 2015
Link to the current ClinicalTrials.gov record.

Condition(s) targeted: Iron Deficiency

Intervention: Ferrous sulfate as dietary supplementation (Other); Iron amino acid chelated as dietary supplementation (Other)

Phase: Phase 3

Status: Completed

Sponsored by: CES University

Official(s) and/or principal investigator(s):
Ana M Herrera, PhD en PatologĂ­a, Study Director, Affiliation: CES University

Summary

Iron deficiency and depleted levels of iron are the most prevalent nutritional deficiency and the leading cause of anemia in the world; this can occur at any age, but preschool children are at particular risk of developing it. This condition may cause serious repercussions for life, being a public health threat of considerable importance worldwide. Food fortification is considered the most effective solution to counter this situation, because it can help more people than other solutions. It is going to carry out a community trial to compare the efficacy of ferrous sulfate with respect to iron amino acid chelate as a dietary supplement in preschool children of Medellin with depleted levels of iron; in terms of increasing ferritin levels in blood and maintain hemoglobin levels. It is hypothesized that at the end of the study the effect of milk fortified with iron amino acid chelate won't be less than the effect of fortified with ferrous sulfate. It is hoped that the results may contribute, albeit indirectly, to improve the health status of children with depleted levels of iron whom consume iron-fortified products.

Clinical Details

Official title: EFICACIA DEL HIERRO AMINOQUELADO COMPARADO CON EL SULFATO FERROSO COMO COMPLEMENTO ALIMENTARIO EN PREESCOLARES CON DEFICIENCIA DE HIERRO.

Study design: Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Supportive Care

Primary outcome: Ferritin

Secondary outcome:

Hemoglobin

Infection

Adverse reaction

Eligibility

Minimum age: 2 Years. Maximum age: 5 Years. Gender(s): Both.

Criteria:

Inclusion Criteria: Children who

- Belong to institute FAN in MedellĂ­n

- Attend full time to institute FAN (eight hours)

- Have 2 to 5 years inclusive

- Submit depleted levels of iron (ferritin level equal to or less than 24 mg/L)

Exclusion Criteria: Children who

- Submit anemia (hemoglobin level equal to or less than 11 g/dL)

- Have not stool analysis before intervention

Locations and Contacts

Universidad CES, Medellin, Antioquia, Colombia
Additional Information

Starting date: October 2011
Last updated: April 10, 2012

Page last updated: August 23, 2015

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017